09:43 AM EDT, 09/16/2025 (MT Newswires) -- Relmada Therapeutics ( RLMD ) said Tuesday it received notification that it regained compliance with Nasdaq's $1 minimum bid price requirement.

To be in compliance with the rule, the biotech company's shares had to have a minimum closing price of $1 for at least 10 consecutive business days, which it said was met on Friday.

Shares of Relmada Therapeutics ( RLMD ) were up over 12% in recent early trading.

Price: 1.88, Change: +0.21, Percent Change: +12.57